# reload+after+2024-01-20 05:44:26.123543
address1§19 Vestry Street
city§New York
state§NY
zip§10013
country§United States
website§https://brightmindsbio.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio of selective 5-HT receptor agonists includes 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry; and BMB-101 which completes phase 1 trial for undisclosed seizure disorder. The company also developing BMB-202 for the treatment of depression, anxiety, and PTSD; and BMB-201 for the treatment of anxiety. It has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. Bright Minds Biosciences Inc. was founded in 2017 and is headquartered in New York, New York.
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Ian  McDonald', 'age': 34, 'title': 'Co-Founder, CEO, President & Director', 'yearBorn': 1989, 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Ryan E. S. K. Cheung B.Com., CA, CPA', 'age': 45, 'title': 'Chief Financial Officer', 'yearBorn': 1978, 'fiscalYear': 2023, 'totalPay': 89713, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Jan Torleif Pedersen M.Sc., Ph.D.', 'age': 58, 'title': 'Chief Science Officer & Director', 'yearBorn': 1965, 'fiscalYear': 2023, 'totalPay': 182080, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Mark A. Smith M.D., Ph.D.', 'age': 68, 'title': 'Chief Medical Officer', 'yearBorn': 1955, 'fiscalYear': 2023, 'totalPay': 244868, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Emer  Leahy M.B.A., Ph.D.', 'age': 56, 'title': 'Consultant', 'yearBorn': 1967, 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1703980800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§1.775
currency§USD
dateShortInterest§1702598400
exchange§NCM
quoteType§EQUITY
shortName§Bright Minds Biosciences Inc.
longName§Bright Minds Biosciences Inc.
firstTradeDateEpochUtc§1616419800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§7de90f41-6566-3a5c-a990-c3e8fec46e3b
gmtOffSetMilliseconds§-18000000
targetHighPrice§4.87
targetLowPrice§4.87
targetMeanPrice§4.87
targetMedianPrice§4.87
recommendationMean§3.0
recommendationKey§hold
numberOfAnalystOpinions§1
quickRatio§24.158
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
